Publications en collaboration avec des chercheurs de Hospital Universitario San Cecilio (42)

2024

  1. Changes in Cortisol and in Oxidative/Nitrosative Stress Indicators after ADHD Treatment

    Antioxidants, Vol. 13, Núm. 1

2022

  1. Dose-Dependent Effect of Melatonin on BAT Thermogenesis in Zücker Diabetic Fatty Rat: Future Clinical Implications for Obesity

    Antioxidants, Vol. 11, Núm. 9

  2. Protective effect of melatonin administration against sars-cov-2 infection: A systematic review

    Current Issues in Molecular Biology, Vol. 44, Núm. 1

2021

  1. Current evidence on the role of the gut microbiome in ADHD pathophysiology and therapeutic implications

    Nutrients, Vol. 13, Núm. 1, pp. 1-32

2020

  1. Indole Tryptophan Metabolism and Cytokine S100B in Children with Attention-Deficit/Hyperactivity Disorder: Daily Fluctuations, Responses to Methylphenidate, and Interrelationship with Depressive Symptomatology

    Journal of Child and Adolescent Psychopharmacology, Vol. 30, Núm. 3, pp. 177-188

  2. Possible Protective Role of Melatonin in Pediatric Infectious Diseases and Neurodevelopmental Pathologies

    Journal of Child Science, Vol. 10, Núm. 1, pp. 104-109

2019

  1. Early monitoring of fatty acid profile in children with attention deficit and/or hyperactivity disorder under treatment with omega-3 polyunsaturated fatty acids

    Minerva Pediatrica, Vol. 71, Núm. 3, pp. 313-325

2018

  1. Clinical Considerations Derived From the Administration of Melatonin to Children With Sleep Disorders

    Pediatric Neurology, Vol. 78, pp. 61-69

2017

  1. Analysis of Different Melatonin Secretion Patterns in Children with Sleep Disorders: Melatonin Secretion Patterns in Children

    Journal of Child Neurology, Vol. 32, Núm. 12, pp. 1000-1008

  2. BDNF concentrations and daily fluctuations differ among ADHD children and respond differently to methylphenidate with no relationship with depressive symptomatology

    Psychopharmacology, Vol. 234, Núm. 2, pp. 267-279

  3. Melatonin treatment reduces oxidative damage and normalizes plasma pro-inflammatory cytokines in patients suffering from charcot-marie-tooth neuropathy: A pilot study in three children

    Molecules, Vol. 22, Núm. 10

  4. Probiotics to prevent necrotising enterocolitis and nosocomial infection in very low birth weight preterm infants

    British Journal of Nutrition, Vol. 117, Núm. 7, pp. 994-1000

2016

  1. Treatments and compositions for attention deficit hyperactivity disorder: A patent review

    Expert Opinion on Therapeutic Patents, Vol. 26, Núm. 7, pp. 799-814

2014

  1. Differential responses of two related neurosteroids to methylphenidate based on ADHD subtype and the presence of depressive symptomatology

    Psychopharmacology, Vol. 231, Núm. 17, pp. 3635-3645

  2. Epidemiology of imported bilharzia: Prophylactic and treatment options for children

    Schistosomiasis: Epidemiology, Diagnosis and Treatment (Nova Science Publishers, Inc.), pp. 171-185

  3. Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes

    International Journal of Molecular Sciences, Vol. 15, Núm. 9, pp. 17115-17129

2013

  1. Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD

    Journal of Psychiatric Research, Vol. 47, Núm. 3, pp. 377-383

2011

  1. Melatonin treatment counteracts the hyperoxidative status in erythrocytes of patients suffering from Duchenne muscular dystrophy

    Clinical Biochemistry, Vol. 44, Núm. 10-11, pp. 853-858

  2. Normalization of the sleep-wake pattern and melatonin and 6-sulphatoxy-melatonin levels after a therapeutic trial with melatonin in children with severe epilepsy

    Journal of Pineal Research, Vol. 50, Núm. 2, pp. 192-196

  3. Psychosocial dwarfism: Psychopathological aspects and putative neuroendocrine markers

    Psychiatry Research, Vol. 188, Núm. 1, pp. 96-101